C9165 HCPCS Level II Code: Injection, elranatamab-bcmm, 1 mg
Medicare Coverage & Payment
- CMS short descriptor: Inj, elranatamab-bcmm, 1 mg
- Medicare coverage: Special coverage instructions apply (CMS coverage code D)
- Pricing indicator: 53
- BETOS: O1D — Chemotherapy
- Last CMS action effective: April 1, 2024
- Terminated: March 31, 2024
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Code Set: Removed from the code set — not valid on or after April 1, 2024.
Change history
- April 1, 2024Removed from the code setInjection, elranatamab-bcmm, 1 mg
- January 1, 2024Added to the code setInjection, elranatamab-bcmm, 1 mg
Contextual Map
Every relationship of C9165 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Nearest codes (40)
- C9136 — Injection, factor viii, fc fusion protein, (recombinant), per i.u.[Sibling]
- C9137 — Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.[Sibling]
- C9138 — Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.[Sibling]
- C9139 — Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.[Sibling]
- C9140 — Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.[Sibling]
- C9141 — Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.[Sibling]
- C9142 — Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg[Sibling]
- C9143 — Cocaine hydrochloride nasal solution (numbrino), 1 mg[Sibling]
- and 32 more
Change history (2)
- April 1, 2024 — Removed from the code set [Change history]
- and 1 more
Nearest Codes in This Family
Official HCPCS Level II classifications closest to C9165 in its code family, with their registry titles.
- C9160 — Injection, daxibotulinumtoxina-lanm, 1 unit
- C9161 — Injection, aflibercept hd, 1 mg
- C9162 — Injection, avacincaptad pegol, 0.1 mg
- C9163 — Injection, talquetamab-tgvs, 0.25 mg
- C9164 — Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)
- C9166 — Injection, secukinumab, intravenous, 1 mg
- C9167 — Injection, adamts13, recombinant-krhn, 10 iu
- C9168 — Injection, mirikizumab-mrkz, 1 mg
- C9169 — Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
- C9170 — Injection, tarlatamab-dlle, 1 mg